MUSC Health, the clinical enterprise of the Medical University of South Carolina (MUSC), is dedicated to the pursuit of changing what’s possible in health care. Nationally recognized for its innovation, patient- and family-centered care, and quality outcomes, this integrated health care system is accessible at the downtown Charleston campus and through more than 100 outreach locations, clinical affiliations with numerous health care partners, and a robust telehealth network. MUSC Health sees more than one million patient encounters annually, and its specialized care teams consistently rank among the best in the country. MUSC Health delivers transformational care shaped by world-class clinicians, health scientists, and educators who provide leading-edge care, while developing the next generation of innovative health care leaders.
Featured Videos |View More
Carsten Krieg, Ph.D.,discusses how “instagrams of the immune system,” captured by a new technology made it possible to identify biomarkers of response to immunotherapy in patients with melanoma.
Lara Wine Lee, M.D, discusses types of vascular anomalies in children, their medical and/or surgical management, the goals of therapy and the multidisciplinary approach taken to their treatment at MUSC Children’s Health.
MUSC Health neurosurgeon Istvan Takacs, M.D., describes how deep brain stimulation (DBS) works, the advantages of performing it awake and how it can dramatically affect the quality of life of patients with movement disorders such as Parkinson’s disease.
In this video, MUSC Health neurosurgeon Alejandro M. Spiotta, M.D. discusses three minimally invasive surgical (MIS) techniques for evacuation of hematoma in patients who experience intracerebral hemorrhage (ICH)
Featured Documents |View More
Conventional biopsies are invasive, costly, and sometimes impossible to conduct, but they yield valuable information other methods were unable to provide—until now.
Stem cells are being tested at the Medical University of South Carolina as a possible treatment for heart failure with a preserved ejection fraction, or HFpEF.
Genomics screening can improve the odds for some cancer patients, potentially identifying mutations associated with cancer subtypes for which targeted therapies exist or are in development.
All content found on this Website, including: video, text, images, audio, or other formats were created for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have seen or read on this Website. If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately. MUSC does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on this website. Reliance on any information provided by this website, MUSC employees, contracted writers, or medical professionals presenting content for publication to MUSC is solely at your own risk. The Site may contain health- or medical-related materials or discussions regarding graphic images, and sexually explicit disease states. If you find these materials offensive, you may not want to use our Site. The Site and its Content are provided on an "as is" basis. Links to educational content not created by MUSC are taken at your own risk. MUSC is not responsible for the claims of external websites and companies.